Runben Biotechnology (SH:603193) Zheng Quan Zhi Xing·2025-09-03 11:17Group 1 - The core opinion of the article is that the legal opinion regarding the convening and holding of the shareholders' meeting of Runben Biotechnology Co., Ltd. is valid and complies with relevant laws and regulations [1][9] - The shareholders' meeting was convened by the company's second board of directors based on the resolution of the ninth meeting held on August 18, 2025, and was presided over by the chairman Zhao Guiqin [2][3] - The meeting was held on September 3, 2025, at the company's conference room in Guangzhou, with provisions for both on-site and online voting [2][4] Group 2 - A total of 396 participants, including shareholders and their proxies, attended the meeting, representing shares that were verified to be held by eligible shareholders as of the registration date [3][5] - The network voting system was made available for all shareholders, allowing them to choose between on-site and online voting, with the first vote counted in case of duplicates [4][5] - The voting results from both on-site and network votes were combined, and the meeting's resolutions were passed in accordance with the company's articles of association [9] Group 3 - The legal opinion confirms that the procedures for convening and holding the shareholders' meeting, the qualifications of attendees, and the voting procedures are all in compliance with legal requirements and the company's articles of association [9] - The resolutions passed during the meeting were deemed legally valid and effective, with specific attention given to the voting results of minority investors [9]